Scientists identify target receptors for the treatment of glioblastoma
the researchers said they identified a type of receptor called protein-tyrosine z phosphatase, or ptprz, as a drug target for patients with glioblastoma.Officially identified the target receptor for the treatment of neuroblastoma
the researchers say they have identified a type of receptor called protein-tyrosine z phosphatase, or ptprz as a potential drug target for patients with glioblastoma.